In: Biology
| Characteristics | Active immunity | Passive immunity |
| exposure to antigen | required | does not require |
| involvement of immune system | actively involved | no active involvement |
| immunity type | humoral and cell mediated immunity | only conferred by readymade antibodies |
| antibody production | yes | no |
| memory cell formation | long lasting memory cells are formed | no |
| secondary response | The first exposure produces primary response and with subsequent exposure to same pathogen, a much faster and stronger secondary response is established. | no secondary responce |
| durability | long-lasting protection | transient protection, short-term |
| response time | takes time because of lag phase |
instant |
| results from |
direct infection vaccination |
injection breast milk through placenta to new born |
| booster doses | subsequent exposure to antigens cause booster effect | subsequent doses are less effective |
| effectiveness | provides effective protection | less effective and may not even be complete |
| components | T cells, B cells and antigen presenting cells | no involvement of immune cells |
| reactivation | Reactivated by recurrence of infection or by revaccination | Frequent re-administration needed for renewed protection |
| examples | Natural –
Production of antibodies in response to exposure to a pathogenic
infection such as SARS-COVID19 or cold.
Artificial – Production of antibodies in response to the controlled exposure to an attenuated pathogen (i.e. vaccination) |
Natural – Receive
antibodies from different organism (e.g. to the foetus via the
colostrum or a newborn via breast milk).
Artificial – Receive manufactured antibodies by external delivery (e.g blood transfusions of monoclonal antibodies) |